Eloxx Pharmaceuticals ELOX
NASDAQ ELOX
$13.20 +0.00 (+0.00%)
As of: Oct 21, 2026 · 3:59 PM EDT

Eloxx Pharmaceuticals (ELOX) Current Debt (2013 - 2014)

Updated

Eloxx Pharmaceuticals' Current Debt came in at -$2.19 million for FY2014, compared with -$12,026 in FY2013.

Analysis

Eloxx Pharmaceuticals (ELOX) Current Debt (2013 - 2014) Analysis & Trends

  • Per Business Quant, earlier years put Current Debt at -$12,026 in FY2013 and $4,264 in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 3.51 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -5.75 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 208.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 64.00 Mn
10 Eloxx Pharmaceuticals 89.68 Mn 16.00 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 -2.19 Mn
Mar 31, 2013 -12,026.00
API Access

Eloxx Pharmaceuticals Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=ELOX&period=max&api_key=YOUR_API_KEY